Atlas Trials

A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

Clinical trial NCT00825084 · COMPLETED

Trial details

NCT number
NCT00825084
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's DiseaseHuntington's Disease
Start date
2009-02-01
Primary completion
2009-05-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.